Study Overview

Details

NCTId: NCT02467647

Status: Unknown status

Condition: Multiple Myeloma

Study Type: Interventional

Sponsor: Wuhan University

Study Description

Brief

To investigate the efficacy of the combination of Thalidomide and Huang-Lian-Jie-Du-Tang on the patients with multiple myeloma in maintain therapy.

Eligibility

Criteria:

Inclusion Criteria:

patients can take HLJDT

Exclusion Criteria:

patients can not take HLJDT

Healthy Volunteers: No

Gender: All

Min Age: 20 Years

Max Age: 85 Years

Contacts

Wuhan University

Recruiting

Wuhan

Hubei

430071

China

Shangqin Liu, Ph.D

Contact

86-27-67812781

[email protected]

Written by